Market Dashboard

Snapshot View

Interactive Charts

Latest Market Commentary

Market Commentary | March 24th, 2025

Mar 24, 2025

Week in Review... Amid the plethora of economic reports and a Federal Open Market Committee (FOMC) meeting, market indices closed the week slightly higher as markets grappled with a resilient economy and future inflation expectations. The S&P 500 rose by 0.51% The...

Market Commentary | March 17th, 2025

Mar 17, 2025

Week in Review... Market indices continued to decline lower as markets continue to navigate the impact of tariffs and softening economic growth. The S&P 500 declined by -2.27% The Dow Jones Industrial Average declined by -3.07% The tech-heavy Nasdaq...

Market Commentary | March 10th, 2025

Mar 10, 2025

Week in Review... Market indices closed the week lower as markets grappled with the timeframe surrounding tariffs and possible labor market softening. The S&P 500 declined by -3.50% The Dow Jones Industrial Average declined by -2.65% The tech-heavy Nasdaq...

Market Commentary | March 3rd, 2025

Mar 3, 2025

Week in Review... Most market indices closed the week lower as new U.S. data sparked concern among investors over a slowing economy and sticky inflation, leading them in search of safer assets. The S&P 500 declined by -0.98% The Dow Jones Industrial Average...

« Older Entries

Next Entries »

Latest Market News from Around the Web

Personal Finance

Boeing CEO says China has stopped taking its aircraft amid trade war
April 24, 2025
CEO Kelly Ortberg said that a few 737 Max planes that were in China set to be delivered to carriers there have been flown back to the U.S.
Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
April 24, 2025
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.
International tourism to the U.S. slumps, but Americans can't stop traveling overseas
April 24, 2025
United Airlines and Delta Air Lines say international and premium travel is robust while domestic coach-class travel and some corporate travel has slowed.
Trump considering exemption for automakers on some tariffs, White House says
April 23, 2025
Trump is considering exemptions for automakers from some tariffs announced by his administration, the White House confirmed Wednesday.

Investment

Thursday’s big stock stories: What’s likely to move the market in the next trading session
April 24, 2025
The major averages booked back-to-back gains on Wednesday, but they settled well off their session highs. Here's what CNBC is watching going into Thursday.
Goldman likes these buy-rated stocks with solid dividend yields
April 23, 2025
The Wall Street investment bank highlighted a list of buy-rated stocks that offer attractive dividends.
These all-weather stocks are beating the market this year. Here's another addition to the list
April 23, 2025
Adding a one-time high beta internet stock to a list of defensive companies would have been unheard of a few years ago, but here we are.
This major bank stock is about to hit resistance and turn lower, says Carter Worth
April 23, 2025
The chart analyst breaks down Morgan Stanley shares.

Stock Market

Stocks making the biggest moves after hours: Chipotle, Texas Instruments, ServiceNow and more
April 23, 2025
These are the stocks posting the largest moves in extended trading.
Stocks making the biggest moves midday: Duolingo, Tesla, Boeing, Gildan Activewear and more
April 23, 2025
These are the stocks posting the largest moves in midday trading.
Stocks making the biggest moves premarket: Boeing, Tesla, BP, Eli Lilly and more
April 23, 2025
These are the stocks posting the largest moves in premarket trading.
Stocks making the biggest moves after hours: Tesla, Enphase Energy, Oklo, Bristol Myers Squibb and more
April 23, 2025
These are the stocks posting the largest moves in extended trading.

Useful Resources & Links

Check the background of investment professionals on FINRA’s BrokerCheck.

Securities offered through Registered Representatives of Cambridge Investment Research, Inc., a broker-dealer, member FINRA/SIPC. Advisory services through Cambridge Investment Research Advisors, Inc., a Registered Investment Advisor. Cambridge and River City Financial are not affiliated. This communication is strictly intended for individuals residing in the states of AL, FL, KY, ME, NC, NJ, OH, SC, TX, VA, WA, WI and WV. No offers may be made or accepted from any resident outside the specific states referenced.

Cambridge’s Form CRS (Customer Relationship Summary)

The information being provided is strictly as a courtesy. When you link to any of these websites provided herein, River City Financial makes no representation as to the completeness or accuracy of information provided at these sites. Nor is the company liable for any direct or indirect technical or system issues or any consequences arising out of your access to or your use of third-party technologies, sites, information, and programs made available through this site.

River City Financial